Fair value (multi-method)
Four independent methods triangulate what AZN is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$1,047.84
Method range
$36.97 – $1,047.84
median $277.32
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $1,047.84 | +463.51% |
| Exit multiple | $338.64 | +82.12% |
| Analyst target | $216.00 | +16.16% |
| Graham number | $36.97 | -80.12% |
- Forward DCF$1,047.84
- Exit multiple$338.64
- Analyst target$216.00
- Graham number$36.97
Stock price
$185.95
FCF / share (TTM)
$1.18
3Y FCF CAGR
30.0%
Fair value @ hist. growth
$346.17
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
21.8%
per year over your projection horizon
Margin of safety 46.3% vs hist-growth DCF
Historical 3Y CAGR
30.0%
Your model implies
21.8%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at 30% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 22.3% | 20.5% | 18.5% | 16.1% | 12.9% |
| 5.0% | 22.3% | 20.5% | 18.5% | 16.1% | 12.9% |
| 5.7% | 24.9% | 23.5% | 21.8% | 19.9% | 17.6% |
| 6.7% | 28.5% | 27.3% | 26.0% | 24.5% | 22.9% |
| 7.7% | 31.6% | 30.6% | 29.6% | 28.4% | 27.1% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.78
Low vs growth
Net debt
$24.0B
Total debt − cash
Beta
0.22
Vs market benchmark
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation